Drug factory · FDA FEI 3008915297

Ablynx

Technologiepark-Zwijnaarde 21 Gent, , Zwijnaarde, Belgium

Belgium: 1

Problems found, fixed voluntarily at FDA's last inspection, May 24, 2024.

Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.

2 drug inspections on record since 2021: 0 with no problems, 2 with problems fixed voluntarily, 0 with FDA action.

What it does, for whom

DrugRoleForNDC
CaplacizumabTests it Genzyme Corporation 58468-0225

FDA inspection history

EndedResultProgramProblems noted
May 24, 2024Problems found, fixed voluntarilyDrug Quality Assurance—
Feb 9, 2021Problems found, fixed voluntarilyDrug Quality Assurance—

Registered with FDA for: analysis; manufacture.